Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, And Blood Institute working group report

Annals of Behavioral Medicine

Volumn 32, Issue 2, 2006, Pages 121-126

  Davidson, Karina W ^a,b   Kupfer, David J ^c   Bigger, J Thomas ^p   Califf, Robert M ^e,f   Carney, Robert M ^e,f   Coyne, James C ^g   Czajkowski, Susan M ^d   Frank, Ellen ^c   Frasure Smith, Nancy ^h   Freedland, Kenneth E ^f   Froelicher, Erika S ⁱ   Glassman, Alexander H ^a   Katon, Wayne J ^j   Kaufmann, Peter G ^d   Kessler, Ronald C ^k   Kraemer, Helena C ^l   Krishnan, K Ranga R ^m   Lespérance, François ^h   Rieckmann, Nina ^b   Sheps, David S ⁿ   Suls, Jerry M ^o   more..

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^k HARVARD MEDICAL SCHOOL   (United States)

^l STANFORD UNIVERSITY   (United States)

^m DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^o E11 SSH   (United States)

^p PH9 Center ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

BECK DEPRESSION INVENTORY; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT TOOL; COGNITIVE THERAPY; COMORBIDITY; CONFERENCE PAPER; DEPRESSION; DEPRESSION INTERVIEW AND STRUCTURED HAMILTON; DRUG MECHANISM; HAMILTON SCALE; HUMAN; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT HEALTH QUESTIONNAIRE 2; PSYCHOTHERAPY; QUALITY OF LIFE; RATING SCALE; SCREENING; SELF EVALUATION; UNSPECIFIED SIDE EFFECT;

ACADEMIC MEDICAL CENTERS; CARDIOVASCULAR DISEASES; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HEART DISEASES; HEMATOLOGIC DISEASES; HUMANS; INTERDISCIPLINARY COMMUNICATION; LUNG DISEASES; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33749647666     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15324796abm3202_9     Document Type: Conference Paper

References (24)

1. Krishnan KRR, Delong M, Kraemer H, et al: Comorbidity of depression with other medical illnesses in the elderly. Biological Psychiatry. 2002, 52:559-588.
2. Berkman LF, Blumenthal J, Burg M, et al.: Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. Journal of the American Medical Association. 2003, 289:3106-3116.
3. Glassman AH, O'Connor CM, Califf RM, et al.: Sertraline treatment of major depression in patients with acute MI or unstable angina. Journal of the American Medical Association. 2002, 288:701-709.
4. Serebruany VL, Suckow RF, Cooper TB, et al.: Sertraline Antidepressant Heart Attack Randomized Trial. Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. American Journal of Psychiatry. 2005, 162:1165-1170.
5. Serebruany VL, Glassman AH, Malinin AI, et al.: Sertraline Antidepressant Heart Attack Randomized Trial Study Group. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: The Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet substudy. Circulation. 2003, 108:939-944.
6. Carney RM, Blumenthal JA, Freedland KE, et al.: Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) Study. Psychosomatic Medicine. 2004, 66:466-474,
7. Taylor CB, Youngblood ME, Catellier D, et al.: Effects of antidepressant medication on morbidity and mortality in depressed post-Mi patients. Archives of General Psychiatry. 2005, 62:792-798.
8. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Archives of General Psychiatry. 1961, 4:561-571.
9. Beck AT, Steer RA, Brown GK: Manual for Beck Depression Inventory II (BDI-II). San Antonio, TX: Psychology Corporation, 1996.
10. Rush AJ, Giles DE, Schlesser MA, et al: The Inventory for Depressive Symptomatology (IDS): Preliminary findings. Psychiatry Research. 1986, 18:65-87.
11. Freedland KE, Skala JA, Carney RM, et al.: The Depression Interview and Structured Hamilton (DISH): Rationale, development, characteristics, and clinical validity. Psychosomatic Medicine. 2002, 64:897-905.
12. Kessler RC, Ustun TB: The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). International Journal of Methods in Psychiatric Research. 2004, 13:93-121.
13. Kessler RC, Demler O, Frank RG, et al.: Prevalence and treatment of mental disorders, 1990 to 2003. New England Journal of Medicine. 2005, 352:2515-2523.
14. Kessler RC, Berglund P, Borges G, Nock M, Wang PS: Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. Journal of the American Medical Association. 2005, 293:2487-2495.
15. Kessler RC, McGonagle KA, Zhao S, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry. 1994, 51:8-19.
16. Strik JJ, Honig A, Lousberg R, Denollet J: Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics. 2001, 42:423-428.
17. Rush AJ, Trivedi MH, Carmody TJ, et al.: Self-reported depressive symptom measures: Sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology. 2005, 30:405-416.
18. Murray CJL, Lopez AD: Global Burden of Disease and Injury: Vol. 1. A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press, 1996.
19. Schatzberg AF, Rush AJ, Arnow BA, et al.: Chronic depression: Medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Archives of General Psychiatry. 2005, 62:513-520.
20. Trivedi MH, Rush AJ, Wisniewski SR, et al.: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. American Journal of Psychiatry. 2006, 163:28-40.
21. Unutzer J, Katon W, Callahan CM, et al.: Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. Journal of the American Medical Association. 2002, 288:2836-2845.
22. Yusuf S, Sleight P, Pogue J, et al.: Effects of an angiotensin- converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. New England Journal of Medicine. 2000, 342:145-153.
23. Moss AJ, Zareba W, Hall WJ, et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine. 2002, 346:877-883.
24. Katon WJ, Von Korff M, Lin EH, et al.: The Pathways Study: A randomized trial of collaborative care in patients with diabetes and depression. Archives of General Psychiatry. 2004, 61:1042-1049.